These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2958141)

  • 1. Sensitization through carcinogen-induced Langerhans cell-deficient skin activates specific long-lived suppressor cells for both cellular and humoral immunity.
    Halliday GM; Muller HK
    Cell Immunol; 1987 Oct; 109(1):206-21. PubMed ID: 2958141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance via skin depleted of Langerhans cells by a chemical carcinogen.
    Halliday GM; Muller HK
    Cell Immunol; 1986 Apr; 99(1):220-7. PubMed ID: 2944623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical carcinogens and antigens induce immune suppression via Langerhans' cell depletion.
    Woods GM; Qu M; Ragg SJ; Muller HK
    Immunology; 1996 May; 88(1):134-9. PubMed ID: 8707340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presented in the local lymph node by cells from dimethylbenzanthracene-treated murine epidermis activates suppressor cells.
    Halliday GM; Cavanagh LL; Muller HK
    Cell Immunol; 1988 Dec; 117(2):289-302. PubMed ID: 2973843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of benzo[a]pyrene and dimethylbenz[a]-anthracene on Langerhans cell distribution and contact sensitization in murine epidermis.
    Ruby JC; Halliday GM; Muller HK
    J Invest Dermatol; 1989 Feb; 92(2):150-5. PubMed ID: 2493054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of antigen to suppressor cells by a dimethylbenz (a) anthracene-resistant, Ia-positive, Thy-1-negative, I-J-restricted epidermal cell.
    Halliday GM; Wood RC; Muller HK
    Immunology; 1990 Jan; 69(1):97-103. PubMed ID: 1968886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble factors in tolerance and contact sensitivity to DNFB in mice. VII. Characterization of a monoclonal, efferent-acting suppressor factor with specificity for DNP/H-2Kd.
    Fairchild RL; Moorhead JW
    Cell Immunol; 1987 Mar; 105(1):147-60. PubMed ID: 2434249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of suppressor T cells to dinitrofluorobenzene contact sensitivity by application of sensitizer through Langerhans cell-deficient skin. II. Kinetics of the induction of suppressor T cells.
    Kanagawa H; Kotake K; Semma M; Sagami S
    J Am Acad Dermatol; 1983 Nov; 9(5):680-5. PubMed ID: 6227638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor cell activation and enhanced skin allograft survival after tumor promotor but not initiator induced depletion of cutaneous Langerhans cells.
    Halliday GM; Odling KA; Ruby JC; Muller HK
    J Invest Dermatol; 1988 Mar; 90(3):293-7. PubMed ID: 2964490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of afferent sensitivity by suppressor T cells in adoptive tolerance.
    Moorhead JW
    J Immunol; 1976 Sep; 117(3):802-6. PubMed ID: 1085311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunologic tolerance to dinitrofluorobenzene following topical application of dinitrothiocyanobenzene: modulation by suppressor T cells.
    Iijima M; Katz SI
    J Invest Dermatol; 1983 Oct; 81(4):325-30. PubMed ID: 6225805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells.
    Qu M; Muller HK; Woods GM
    Carcinogenesis; 1997 Jun; 18(6):1277-9. PubMed ID: 9214614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of an established immune response via chemical carcinogen or UVB-altered skin.
    Chen YP; Woods GM; Dandie GW; Muller HK
    Immunol Cell Biol; 1997 Jun; 75(3):238-44. PubMed ID: 9243288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of suppressor T cells to DNFB contact sensitivity by application of sensitizer through Langerhans cell-deficient skin.
    Semma M; Sagami S
    Arch Dermatol Res; 1981; 271(3):361-4. PubMed ID: 6458249
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble factors in tolerance and contact sensitivity to 2,4-dinitrofluorobenzene in mice. I. Suppression of contact sensitivity by soluble suppressor factor released in vitro by lymph node cell populations containing specific suppressor cells.
    Moorhead JW
    J Immunol; 1977 Jul; 119(1):315-21. PubMed ID: 874323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressor T cell circuits in contact sensitivity. II. Induction and characterization of an efferent-acting, antigen-specific, H-2-restricted, monoclonal T cell hybrid-derived suppressor factor specific for DNFB contact hypersensitivity.
    Miller SD
    J Immunol; 1984 Dec; 133(6):3112-20. PubMed ID: 6208271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of tolerance to urushiol by epicutaneous application of this hapten on dinitrofluorobenzene-treated skin.
    Hanau D; Stampf JL; Fabre M; Grosshans E; Benezra C
    J Invest Dermatol; 1985 Jul; 85(1):9-11. PubMed ID: 3159803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact hypersensitivity is suppressed after sensitisation by dinitrofluorobenzene of early stage iso-skin grafts.
    Yasuda H; Murayama M; Yamamoto O; Asahi M
    Scand J Plast Reconstr Surg Hand Surg; 1996 Sep; 30(3):169-75. PubMed ID: 8885010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical application of lipopolysaccharide on contact hypersensitivity.
    Tanaka M; Kohchi C; Inagawa H; Ikemoto T; Hara-Chikuma M
    Biochem Biophys Res Commun; 2022 Jan; 586():100-106. PubMed ID: 34837833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential inhibition of contact sensitivity by suppressor T cells and suppressor factor induced by combined treatment with dinitrobenzenesulphonate and dinitrofluorobenzene.
    Zimber C; Ben-Efraim S; Weiss DW
    Immunology; 1982 Mar; 45(3):449-57. PubMed ID: 6460687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.